A nuclear matrix attachment site in the 4q35 locus has an enhancer-blocking activity in vivo: Implications for the facio-scapulo-humeral dystrophy

Genome Research

Volumn 18, Issue 1, 2008, Pages 39-45

  Petrov, Andrei ^a   Allinne, Jeanne ^a   Pirozhkova, Iryna ^a   Laoudj, Dalila ^b   Lipinski, Marc ^a   Vassetzky, Yegor S ^a  

^a UMR 8126   (France)

^b Institut National de la Santé et de la Recherche Médical ER125   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 4Q; CHROMOSOME DELETION; CONTROLLED STUDY; ENHANCER REGION; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FRG1 GENE; FRG2 GENE; GENE; GENE LOCUS; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MATRIX ATTACHMENT REGION; MOLECULAR CLONING; MYOBLAST; PREVALENCE; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION REGULATION;

CHROMOSOMES, HUMAN, PAIR 4; ENHANCER ELEMENTS (GENETICS); HELA CELLS; HUMANS; MATRIX ATTACHMENT REGIONS; MODELS, GENETIC; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; NUCLEAR PROTEINS; PROTEINS; QUANTITATIVE TRAIT LOCI; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 38049094992     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.6620908     Document Type: Article

References (30)

1. Bode, J., Benham, C., Knopp, A., and Mielke, C. 2000. Transcriptional augmentation: Modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit. Rev. Eukaryot. Gene Expr. 10: 73-90.
2. Cockerill, P.N. and Garrard, W.T. 1986. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44: 273-282.
3. de Greef, J.C., Wohlgemuth, M., Chan, O.A., Hansson, K.B., Smeets, D., Frants, R.R., Weemaes, C.M., Padberg, G.W., and van der Maarel, S.M. 2007. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology 69: 1018-1026.
4. Gabellini, D., Green, M.R., and Tupler, R. 2002. Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110: 339-348.
5. Gabellini, D., D'Antona, G., Moggio, M., Prelle, A., Zecca, C., Adami, R., Angeletti, B., Ciscato, P., Pellegrino, M.A., Bottinelli, R., et al. 2005. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 439: 973-977
6. Gabriels, J., Beckers, M.C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S.M., Padberg, G.W., Frants, R.R., Hewitt, J.E., Collen, D., et al. 1999. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236: 25-32.
7. Gasser, S.M. and Vassetzky, Y.S. 1998. Analysis of nuclear scaffold attachment regions. In Chromatin: A Practical Approach (ed. H. Gould), pp. 111-124. Oxford University Press, Oxford, UK.
8. Gaszner, M. and Felsenfeld, G. 2006. Insulators: Exploiting transcriptional and epigenetic mechanisms. Nat. Rev. Genet. 7: 703-713. doi: 10.1038/nrg1925.
9. Girard-Reydet, C., Gregoire, D., Vassetzky, Y., and Mechali, M. 2004. DNA replication initiates at domains overlapping with nuclear matrix attachment regions in the xenopus and mouse c-myc promoter. Gene 332: 129-138.
10. Gromova, I.I., Thomsen, B., and Razin, S.V. 1995. Different topoisomerase II antitumor drugs direct similar specific long-range fragmentation of an amplified c-MYC gene locus in living cells and in high-salt-extracted nuclei. Proc. Natl. Acad. Sci. 92: 102-106.
11. Horike, S., Cai, S., Miyano, M., Cheng, J.F., and Kohwi-Shigematsu, T. 2005. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat. Genet. 37: 31-40. doi: 10.1038/ng1491.
12. Ioudinkova, E., Petrov, A., Razin, S.V., and Vassetzky, Y.S. 2005. Mapping long-range chromatin organization within the chicken α-globin gene domain using oligonucleotide DNA arrays. Genomics 85: 143-151.
13. Kalos, M. and Fournier, R.E. 1995. Position-independent transgene expression mediated by boundary elements from the apolipoprotein B chromatin domain. Mol. Cell. Biol. 15: 198-207.
14. Laoudj-Chenivesse, D., Carnac, G., Bisbal, C., Hugon, G., Bouillot, S., Desnuelle, C., Vassetzky, Y., and Fernandez, A. 2005. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J. Mol. Med. 83: 216-224.
15. Lunt, P.W. and Harper, P.S. 1991. Genetic counselling in facioscapulohumeral muscular dystrophy. J. Med. Genet. 28: 655-664.
16. Mirkovitch, J., Mirault, M.E., and Laemmli, U.K. 1984. Organization of the higher-order chromatin loop: Specific DNA attachment sites on nuclear scaffold. Cell 39: 223-232.
17. Petrov, A.P., Laoudj, D., and Vassetzky, Y.S. 2003. Genetics and epigenetics of progressive facioscapulohumeral (Landouzy-Dejerine) muscular dystrophy. Genetika 39: 147-151.
18. Petrov, A., Pirozhkova, I., Laoudj, D., Carnac, G., Lipinski, M., and Vassetzky, Y.S. 2006. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc. Natl. Acad. Sci. 103: 6982-6987.
19. Rijkers, T., Deidda, G., van Koningsbruggen, S., van Geel, M., Lemmers, R.J., van Deutekom, J.C., Figlewicz, D., Hewitt, J.E., Padberg, G.W., Frants, R.R., et al. 2004. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients. J. Med. Genet. 41: 826-836.
20. Schubeler, D., Mielke, C., and Bode, J. 1997. Excision of an integrated provirus by the action of FLP recombinase. In Vitro Cell. Dev. Biol. 33: 825-830.
21. Stratling, W.H. and Yu, F. 1999. Origin and roles of nuclear matrix proteins. Specific functions of the MAR-binding protein MeCP2/ARBP. Crit. Rev. Eukaryot. Gene Expr. 9: 311-318.
22. Tupler, R., Perini, G., Pellegrino, M.A., and Green, M.R. 1999. Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy. Proc. Natl. Acad. Sci. 96: 12650-12654.
23. van der Maarel, S.M., Frants, R.R., and Padberg, G.W. 2006. Facioscapulohumeral muscular dystrophy. Biochim Biophys Acta 1772: 186-194.
24. van Deutekom, J.C., Wijmenga, C., van Tienhoven, E.A., Gruter, A.M., Hewitt, J.E., Padberg, G.W., van Ommen, G.J., Hofker, M.H., and Frants, R.R. 1993. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum. Mol. Genet. 2: 2037-2042.
25. van Geel, M., Heather, L.J., Lyle, R., Hewitt, J.E., Frants, R.R., and de Jong, P.J. 1999. The FSHD region on human chromosome 4q35 contains potential coding regions among pseudogenes and a high density of repeat elements. Genomics 61: 55-65.
26. van Koningsbruggen, S., Straasheijm, K.R., Sterrenburg, E., de Graaf, N., Dauwerse, H.G., Frants, R.R., and van der Maarel, S.M. 2006. FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma 116: 53-64.
27. van Overveld, P.G., Lemmers, R.J., Sandkuijl, L.A., Enthoven, L., Winokur, S.T., Bakels, F., Padberg, G.W., van Ommen, G.J., Frants, R.R., and van der Maarel, S.M. 2003. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35: 315-317. doi: 10.1038/ng1262.
28. Vassetzky, Y., Lemaitre, J.M., and Mechali, M. 2000. Specification of chromatin domains and regulation of replication and transcription during development. Crit. Rev. Eukaryot. Gene Expr. 10: 31-38.
29. Winokur, S.T., Chen, Y.W., Masny, P.S., Martin, J.H., Ehmsen, J.T., Tapscott, S.J., Van Der Maarel, S.M., Hayashi, Y., and Flanigan, K.M. 2003. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 12: 2895-2907.
30. Wohlgemuth, M., Lemmers, R.J., Van Der Kooi, E.L., Van Der Wielen, M.J., Van Overveld, P.G., Dauwerse, H., Bakker, E., Frants, R.R., Padberg, G.W., and Van Der Maarel, S.M. 2003. Possible phenotypic dosage effect in patients compound heterozygous for FSHD-sized 4q35 alleles. Neurology 61: 909-913.